Author： Vincenzi Bruno Santini Daniele Russo Antonio Gavasci Michele Battistoni Fabrizio Dicuonzo Giordano Rocci Laura Rosaria Valerio Maria Gebbia Nicola Tonini Giuseppe
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.8, Iss.4, 2007-04, pp. : 319-327
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
By Kim Sun Hong Yong Kim Byung Park Ji Choi Hyo Jeong Seung-Yong Kim Dae Hong Chang Sohn Dae Jung Kyung
Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. :
Access to resources
Recommend
By Méndez M. Alfonso P. Pujol E. González E. Castañon C. Cerezuela P. López-Mateos Y. Cruz J.
Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. :
By Kang Myoung
Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. :
Cetuximab launched in Japan for advanced colorectal cancer
Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. :
Benefit-Risk Assessment of Irinotecan in Advanced Colorectal Cancer
Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. :